FARALLON CAPITAL MANAGEMENT LLC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 257 filers reported holding AXSOME THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 1.16 and the average weighting 0.5%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$322,000
+0.9%
4,0000.0%0.00%
+100.0%
Q1 2024$319,200
+0.3%
4,0000.0%0.00%0.0%
Q4 2023$318,360
-96.4%
4,000
-96.8%
0.00%
-97.6%
Q3 2023$8,781,888
-55.2%
125,653
-53.9%
0.04%
-58.2%
Q2 2023$19,603,408
-57.1%
272,800
-38.3%
0.10%
-68.2%
Q4 2019$45,708,000
+464.6%
442,222
+10.6%
0.31%
+404.9%
Q3 2019$8,096,000400,0000.06%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q1 2024
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 991,754$58,345,00037.79%
VR Adviser, LLC 810,000$47,652,00012.91%
ACUTA CAPITAL PARTNERS, LLC 308,500$18,149,0008.80%
Fairmount Funds Management LLC 189,598$11,154,0006.76%
RA Capital Management 1,904,094$112,018,0003.54%
Ghost Tree Capital, LLC 215,000$12,648,0003.36%
MORGAN JESS S & CO INC 42,402$2,495,0003.24%
RTW INVESTMENTS, LP 1,052,969$61,946,0002.67%
EAM Global Investors LLC 50,649$2,980,0001.74%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,172,014$68,950,0001.67%
View complete list of AXSOME THERAPEUTICS INC shareholders